A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer

The authors identified a novel, reliable prognostic signature for colon cancer. The study provided new insights into the function of CRs and has important clinical implications for immunotherapy for colon cancer.